Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.23M 2.98M 2.6M 2.39M 2.23M 284M 4.3M 28.8M 11.16M 139M 11.19M 10.95M 480M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 5.21M 3.68M 3.21M 2.95M 2.75M 350M 5.3M 35.51M 13.76M 172M 13.8M 13.5M 591M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.98M | |
| +0.64% | +6.14% | +1.90% | +7.18% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +5.46% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| +0.43% | +0.70% | +13.80% | +19.23% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | -2.32% | +6.43% | +70.96% | +103.33% | 26.92B | |
| Weighted average by Cap. | +1.31% | +6.73% | +88.44% | +131.04% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.27M -1.11M -1.02M -950K -121M -1.83M -12.27M -4.75M -59.29M -4.77M -4.66M -204M | 5M 3.52M 3.08M 2.83M 2.64M 335M 5.08M 34.04M 13.19M 165M 13.23M 12.94M 567M |
| Net Debt | 795K 560K 490K 450K 419K 53.35M 808K 5.41M 2.1M 26.17M 2.1M 2.06M 90.16M | 986K 695K 607K 558K 520K 66.15M 1M 6.71M 2.6M 32.44M 2.61M 2.55M 112M |
Employees
-
